<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://hdl.handle.net/123456789/1974">
<title>COMPARATIVE EFFECTS OF OVERGROUND WALKING EXERCISE AND COGNITIVE REHABILITATION ON COGNITION, BRAINDERIVED NEUROTROPHIC FACTOR, QUALITY OF LIFE AND PARTICIPATION RESTRICTION AMONG STROKE SURVIVORS</title>
<link>http://hdl.handle.net/123456789/1974</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://hdl.handle.net/123456789/1975"/>
</rdf:Seq>
</items>
<dc:date>2026-04-15T02:36:16Z</dc:date>
</channel>
<item rdf:about="http://hdl.handle.net/123456789/1975">
<title>COMPARATIVE EFFECTS OF OVERGROUND WALKING EXERCISE AND COGNITIVE REHABILITATION ON COGNITION, BRAINDERIVED NEUROTROPHIC FACTOR, QUALITY OF LIFE AND PARTICIPATION RESTRICTION AMONG STROKE SURVIVORS</title>
<link>http://hdl.handle.net/123456789/1975</link>
<description>COMPARATIVE EFFECTS OF OVERGROUND WALKING EXERCISE AND COGNITIVE REHABILITATION ON COGNITION, BRAINDERIVED NEUROTROPHIC FACTOR, QUALITY OF LIFE AND PARTICIPATION RESTRICTION AMONG STROKE SURVIVORS
ABBA, Muhammad Aliyu
Post-Stroke Cognitive Impairment (PSCI) is a major cause of disability, dependence on Activities of&#13;
Daily Living (ADL), Participation Restriction (PR) and poor Quality of Life (QoL). Evidence has shown&#13;
that the gold standard for PSCI rehabilitation is Cognitive Rehabilitation (CR). Studies have also shown&#13;
that aerobic exercises with treadmills and bicycle ergometers are effective in the management of PSCI.&#13;
However, only few studies have examined the effects of Overground Walking Exercise (OWE), which&#13;
is an inexpensive, accessible and natural form of aerobic exercise. This study was conducted to&#13;
investigate the comparative effects of an eight-week OWE and Cognitive Rehabilitation (CR) on&#13;
cognition, Brain-Derived Neurotrophic Factor (BDNF), QoL and PR among stroke survivors.&#13;
The study design was randomised-controlled trial, which involved 53 stroke survivors with mild-tomoderate cognitive impairments, purposively recruited from three tertiary hospitals in Kano, and&#13;
randomly assigned into three groups using computer-generated random numbers. The participants&#13;
received moderate-intensity self-paced OWE, Zoltan protocol CR and combined interventions in the&#13;
respective groups (OWEG=17, CRG=18 and OWECRG=18). Each group received thrice weekly&#13;
interventions for eight weeks. About 5 ml venous blood sample was collected aseptically, allowed to&#13;
clot and centrifuged to harvest the serum sample. Cognition, serum BDNF (ng/ml), QoL and PR were&#13;
assessed using Montreal Cognitive Assessment, Enzyme-Linked Immunosorbent Assay (ELISA)&#13;
technique, Stroke-Specific Quality of Life questionnaire and London Handicap Scale, respectively at&#13;
baseline, 4th week and 8th week. Data were summarised using descriptive statistics and ANOVA at&#13;
α0.05.&#13;
Age of participants was 48.42±27.39 years. At baseline, duration since stroke onset was 26.70±27.25&#13;
months. The OWEG, CRG and OWECRG were comparable in cognition (18.06±3.60; 19.00±3.90;&#13;
19.50±3.85); BDNF levels (13.05±8.27; 13.81±11.04; 9.54±6.46); QoL (191.00±28.85; 202.72±28.83;&#13;
197.44±39.83) and PR (12.06±4.02; 10.39±4.24; 10.56±3.31) at baseline. Within-group comparisons at&#13;
week 4 showed significant improvements in cognition (20.53±2.83; 22.78±3.95; 22.44±3.37); BDNF&#13;
levels (13.88±8.26; 15.62±12.98; 11.54± 9.17) and QoL (202.24±22.49; 211±21.99; 204.17±41.24) for&#13;
the OWEG, CRG and OWECRG, respectively. The PR significantly decreased to 9.00±2.45; 9.56±2.73&#13;
and 9.44±3.47 at week 4 for the OWEG, CRG and OWECRG, respectively. Similarly, within-group&#13;
comparisons at week 8 showed significant improvements in cognition (26.24±2.51; 25.22±3.26;&#13;
25.17±3.47); BDNF levels (14.69±8.85; 18.13±14.96; 13.35±10.56) and QoL (243.53±17.84;&#13;
222.89±18.35; 221.28±25.72) for the OWEG, CRG and OWECRG, respectively. There were significant&#13;
reductions in PR to 7.24±2.05; 8.39±2.70; 8.39±2.43 at week 8 for the OWEG, CRG and OWECRG,&#13;
respectively. There was no significant across-group difference in cognition, BDNF levels and PR. The&#13;
percentage mean changes at week 8 in cognition (45.3%, 32.7%, 30.5%) and PR (40.0%, 19.3%, 20.6%)&#13;
were highest for the OWEG, while the percentage mean change in BDNF level was highest in the&#13;
OWECRG (12.6%, 31.3%, 38.3%). There was a significant across-group difference in QoL at week 8,&#13;
with the best improvement observed in the OWEG.&#13;
Overground walking exercise, cognitive rehabilitation and a combination of both had comparable&#13;
positive effects on cognition, level of brain-derived neurotrophic factor, and participation. However,&#13;
overground walking exercise resulted in better improvement in participants’ quality of life.
</description>
<dc:date>2023-09-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
